Bausch Health (BHC) news
Recent news
Paulson reduces MDGL, AAMI in 2Q: 13F
Paulson & Co Inc. reduced its stake in Madrigal Pharmaceuticals (MDGL) and Brightsphere Investment Group (AAMI) during the second quarter of 2026, according to latest SEC 13F filing . The firm sold $117 million worth of MDGL shares, marking a 10% reduction in its position, while trimming its AAMI…
AInvest Wire · Aug 14, 2026Bausch Health CEO Thomas J. Appio joins Bausch + Lomb board
AInvest Wire · Aug 6, 2026Bausch Health CEO Thomas J. Appio joins Bausch + Lomb board
Bausch Health Companies Inc. (NYSE/TSX: BHC) announced in May 2022 that Thomas J. Appio appointed CEO and joined the Board of Directors. Appio, who has extensive experience in the pharmaceutical and healthcare sectors, previously held leadership roles at Bausch + Lomb and Schering-Plough. His…
AInvest Wire · Aug 6, 2026Bausch Health Companies shares rise 15% after quarterly results beat estimates
Bausch Health Companies Inc. (NYSE:BHC) reported first-quarter 2026 financial results that exceeded market expectations, driving a 15% increase in its stock price following the announcement. The company posted consolidated revenues of $2.52 billion, up 12% year-over-year, with organic revenue…
AInvest Wire · Jul 30, 2026Bausch Health 2Q EPS 68c vs. 40c y/y
AInvest Wire · Jul 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.